Valuation: Southern Acids (M)

Market Cap 415M 102M 89.24M 82.38M 76.93M 145M 9.64B 148M 991M 383M 4.75B 383M 374M 16.5B P/E 2024
32.3x
P/E 2025 11.4x
Enterprise Value 48.03M 11.8M 10.33M 9.54M 8.91M 16.77M 1.12B 17.15M 115M 44.31M 550M 44.31M 43.34M 1.91B EV / Sales 2024
0.07x
EV / Sales 2025 0.05x
Free-Float
26.64%
Yield 2024
1.55%
Yield 2025 1.64%
Current month-1.26%
1 month-1.26%
3 months+3.97%
6 months-1.26%
Current year-1.26%
1 week 3.14
Extreme 3.14
3.14
1 month 3.1
Extreme 3.1
3.28
Current year 2.99
Extreme 2.99
3.5
1 year 2.99
Extreme 2.99
3.6
3 years 2.82
Extreme 2.82
3.85
5 years 2.82
Extreme 2.82
4.3
10 years 2.7
Extreme 2.7
5.25
Manager TitleAgeSince
Chief Executive Officer 47 14/07/2015
Director of Finance/CFO 58 30/09/2013
Chief Tech/Sci/R&D Officer 38 15/07/2014
Director TitleAgeSince
Director/Board Member 66 09/08/2005
Director/Board Member 59 19/03/2012
Chairman 79 14/07/2015
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-4.85%-8.99% 106M
+6.65%+0.08%+4.02%+316.73% 5.06B
-0.14%+2.02%+14.80%+95.03% 1.66B
+10.07%+2.89%+36.44%+65.99% 734M
+2.07%-4.82%+51.99%+12.55% 653M
-0.32%-0.80%+28.63%+98.08% 509M
+1.17%-3.00%-23.41%-29.18% 487M
-1.85%-11.13%+72.31%+8.66% 426M
-2.14%-1.72%+1.67%-0.27% 362M
-0.27%+0.39%+26.01%+61.74% 305M
Average +1.52%-1.32%+20.76%+62.03% 1.03B
Weighted average by Cap. +3.97%+0.21%+14.33%+181.97%

Financials

2024 2025
Net sales 920M 226M 198M 183M 171M 321M 21.37B 329M 2.2B 849M 10.54B 849M 830M 36.6B 1.11B 272M 238M 220M 205M 386M 25.69B 395M 2.64B 1.02B 12.67B 1.02B 998M 43.99B
Net income 13.63M 3.35M 2.93M 2.71M 2.53M 4.76M 317M 4.87M 32.58M 12.58M 156M 12.58M 12.3M 542M 36.7M 9.02M 7.89M 7.29M 6.81M 12.81M 852M 13.1M 87.7M 33.85M 420M 33.86M 33.11M 1.46B
Net Debt -372M -91.43M -80.06M -73.9M -69.01M -130M -8.64B -133M -889M -343M -4.26B -343M -336M -14.81B -367M -90.12M -78.91M -72.85M -68.03M -128M -8.52B -131M -877M -338M -4.2B -338M -331M -14.59B
Logo Southern Acids (M)
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products and investments in other palm oil related sectors. The Company’s segments include Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The Oleochemical Manufacturing Segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The Healthcare Services operates Sri Kota Specialist Medical Center (Sri Kota), a private tertiary hospital located in Klang, Selangor. The Milling & Cultivation segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (CPO) and palm kernels, as well as oil palm cultivation. Milling & Cultivation operates approximately two palm oil mills (POM) located in Riau, Indonesia with a combined milling capacity of approximately 100 metric tons (MT) per hour.
Employees
1,683
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. 5134 Stock